AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · IEX Real-Time Price · USD
2.970
-0.090 (-2.94%)
At close: Jul 19, 2024, 4:00 PM
3.000
+0.030 (1.01%)
Pre-market: Jul 22, 2024, 7:02 AM EDT
AbCellera Biologics Revenue
AbCellera Biologics had revenue of $35.79M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $9.95M. In the year 2023, AbCellera Biologics had annual revenue of $38.03M.
Revenue (ttm)
$35.79M
Revenue Growth
-80.23%
P/S Ratio
24.40
Revenue / Employee
$61,072
Employees
586
Market Cap
873.34M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 38.03M | -447.40M | -92.17% |
Dec 31, 2022 | 485.42M | 110.22M | 29.38% |
Dec 31, 2021 | 375.20M | 142.05M | 60.92% |
Dec 31, 2020 | 233.16M | 221.54M | 1,907.88% |
Dec 31, 2019 | 11.61M | 2.78M | 31.49% |
Dec 31, 2018 | 8.83M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Healthcare Services Group | 1.68B |
InnovAge Holding | 741.33M |
Pacira BioSciences | 681.75M |
GeneDx Holdings | 221.85M |
Harrow Health | 138.68M |
Cronos Group | 93.03M |
AnaptysBio | 22.96M |
Liquidia | 15.97M |
ABCL News
- 26 days ago - AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 - Business Wire
- 7 weeks ago - AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 - Business Wire
- 2 months ago - AbCellera Reports Q1 2024 Business Results - Business Wire
- 2 months ago - AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies - Business Wire
- 3 months ago - AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 - Business Wire
- 3 months ago - AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 - Business Wire
- 4 months ago - AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 - Business Wire
- 4 months ago - AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions - Business Wire